The Impact of Uremic Toxins on Cerebrovascular and Cognitive Disorders

Archive ouverte

Assem, Maryam | Lando, Mathilde | Grissi, Maria | Kamel, Saïd | Massy, Ziad A. | Chillon, Jean-Marc | Henaut, Lucie

Edité par CCSD ; MDPI -

International audience. Individuals at all stages of chronic kidney disease (CKD) have a higher risk of developing cognitive disorders and dementia. Stroke is also highly prevalent in this population and is associated with a higher risk of neurological deterioration, in-hospital mortality, and poor functional outcomes. Evidence from in vitro studies and in vivo animal experiments suggests that accumulation of uremic toxins may contribute to the pathogenesis of stroke and amplify vascular damage, leading to cognitive disorders and dementia. This review summarizes current evidence on the mechanisms by which uremic toxins may favour the occurrence of cerebrovascular diseases and neurological complications in CKD.

Suggestions

Du même auteur

Metformin alleviates stroke severity in female mice with chronic kidney disease through AMPK activation and subsequent decrease of microglia/macrophages M1 polarization

Archive ouverte | Grissi, Maria | CCSD

56th Congress of the European-Renal-Association (ERA)-European-Dialysis-and-Transplant-Association (EDTA) - Burden, Access and Disparities in Kidney Disease, Budapest, HUNGARY, JUN 13-16, 2019. International audience

Cellular and molecular mechanisms associated with ischemic stroke severity in female mice with chronic kidney disease

Archive ouverte | Henaut, Lucie | CCSD

International audience. Ischemic stroke is highly prevalent in chronic kidney disease (CKD) patients and has been associated with a higher risk of neurological deterioration and in-hospital mortality. To date, littl...

SPIRONOLACTONE ALLEVIATES ISCHEMIC STROKE SEVERITY IN MALE MICE WITH CHRONIC KIDNEY DISEASE

Archive ouverte | Lando, Mathilde | CCSD

57th ERA-EDTA Congress, ELECTR NETWORK, JUN 06-09, 2020. International audience

Chargement des enrichissements...